Events

Info session: FutureFoods Partnership First Project Call
NOV
Tue
05
09:30 - 12:00

This was 8 months ago

Location

Brussels

Simon Bolivarlaan 17
1000 Brussel
Meeting room: (3.N.04)
Programmes
Agro-Food, Environment

FutureFoodS is an innovative European partnership focused on transforming Europe's food production and consumption towards more sustainable and resilient systems. 

The first FutureFoodS co-funded call will open on November 6th.  This call offers funding for innovative projects that contribute to one of the following topics: 

  • Topic 1: The way towards sustainable and resilient food systems
  • Topic 2: New foods – Fostering innovations in food design, processing and supply via demand and supply reorientation 
  • Topic 3: Empowering sustainable food choices - Enabling environments and dietary shifts

FWO, Flanders' FOOD, and VLAIO are organizing a joint info session for this call on Tuesday, November 5, in room 3.N.04 of the Belpaire Building, Simon Bolivarlaan 17, 1000 Brussels, from 9:30 a.m. to 12:00 p.m.

Participation is free, but registration is required and can be done by emailing ann.joris@vlaio.be

Please access the dedicated page for more information. 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.